Tranexamic acid (also called trans-4-aminomethyl cyclohexanecarboxylic acid) is typically used at 2–5% w/w concentration in underarm creams targeting hyperpigmentation, post-inflammatory hyperpigmentation (PIH), or general brightening. Kojic acid or its stabilized derivative, kojic acid dipalmitate, is usually formulated at 1–3% w/w. These ranges are based on efficacy studies, safety data, and what's commonly found in retail products; however, efficacy varies with pH, emulsion stability, and whether the formula includes synergistic actives like niacinamide or licorice extract. There is no universal regulatory cap on either ingredient for cosmetics in most major markets (US, EU, China), but formulation strategy and stability validation determine what concentration is legally defensible and commercially viable.
Transexamic acid in topical applications has been studied extensively for melasma, post-inflammatory hyperpigmentation, and general skin brightening, with effective concentrations ranging from 2–10% in clinical trials. However, most commercial underarm creams use 2–5% because higher concentrations do not proportionally increase efficacy and can create texture or cost issues. Below 2%, efficacy becomes questionable unless the formula includes other depigmenting synergists. Tranexamic acid works by inhibiting plasmin-mediated melanosome transfer and reducing TNF-alpha production in melanocytes; this mechanism requires adequate penetration and residence time in the epidermis, which an underarm cream formulation (typically left on for hours) supports. Stability is a critical constraint: tranexamic acid is susceptible to hydrolysis in aqueous environments, especially at neutral or high pH. Most formulations maintain pH 4.0–5.5 to preserve tranexamic acid's integrity; if your cream sits above pH 5.5 for more than a few months, potency loss accelerates. A proper preservative system (phenoxyethanol, methylchloroisothiazolinone-based preservatives, or newer preservative blends) prevents microbial growth that would otherwise lower pH and trigger hydrolysis. When specifying your formula to a cosmetic chemist, explicitly request a stabilized tranexamic acid formulation with validated stability data at pH 4.5–5.5 over 12 months at room temperature and 8 weeks at 40°C/75% RH.
Kojic acid (5-hydroxy-2-hydroxymethyl-4-pyrone) similarly targets melanin production, but pure kojic acid powder is notoriously unstable—it oxidizes rapidly in water and air, turning brown and losing efficacy within weeks. This is why many manufacturers prefer kojic acid dipalmitate, a derivative in which palmitic acid is esterified to kojic acid, dramatically improving shelf life and stability. Kojic acid dipalmitate is used at 1–3% w/w; it's more stable than free kojic acid but requires a preservative system and slightly acidic pH (4.5–6.0) to prevent ester hydrolysis. Some formulations use both tranexamic acid and kojic acid dipalmitate in a single cream, targeting multiple pathways of melanin regulation; this combination is synergistic but requires careful pH and preservative balance because the two actives can interfere if not properly solubilized. Kojic acid at concentrations above 3% can cause skin irritation or sensitization in some users, especially on sensitive underarm skin; most commercially available underarm creams with kojic acid stay at or below 2% for safety and tolerability.
Safety considerations are paramount for underarm formulations. The underarm is one of the most permeable regions of the skin (thin epidermis, high surface area, warm and moist microclimate), meaning any active ingredient will have higher dermal absorption than if applied to forearm or cheek. Tranexamic acid is generally recognized as safe (GRAS) in cosmetics by most regulatory bodies; no maximum concentration limit exists in the US or EU for topical tranexamic acid in cosmetics. However, systemic absorption is theoretically possible with large, repeated applications, so formulators typically stay conservative (2–5%) and include cautionary language on the label ("for external use only," "discontinue if irritation occurs"). Kojic acid, likewise, has no hard regulatory ceiling in most markets, but case reports of contact dermatitis and sensitization exist at higher concentrations; concentrations of 1–2% are considered safe for regular underarm use, while 3% and above warrant patch-test recommendations or explicit irritation warnings on the label. If your target market includes sensitive-skin consumers (a common underarm cream claim), keep tranexamic acid at 2–3% and kojic acid at 1–2% and include a hypoallergenic or dermatologist-tested claim if you have supporting data.
Regulatory differences matter. In the US (FDA), both tranexamic acid and kojic acid are permissible cosmetic ingredients with no concentration limits, though the FDA scrutinizes any claim that implies a drug effect (e.g., "treats dark spots" vs. "brightens the appearance of"); if you claim therapeutic efficacy, your product crosses into drug territory and requires clinical data or an IND (Investigational New Drug) application. In the EU, tranexamic acid is not listed in Annex III (banned/restricted substances) and is permissible; kojic acid is also permitted, but the EU restricts some derivatives and impurities, so source your kojic acid or dipalmitate from a supplier who provides a Certificate of Analysis confirming purity and absence of restricted dyes or heavy metals. In China (NMPA), both ingredients are permitted in cosmetics; if you're selling into China, they will be listed on your product's packaging in Chinese and must be registered in the NMPA's cosmetics ingredient database. Australia (TGA) permits both at typical cosmetic concentrations. Japan's Ministry of Health, Labour and Welfare (MHLW) permits tranexamic acid but classifies kojic acid in a gray zone—it's not explicitly banned, but some regional prefectures have restricted it due to historical concerns about sensitization; verify local rules if entering the Japanese market.
Common formulation mistakes: (1) Using free kojic acid powder instead of dipalmitate and expecting shelf life beyond 6 months—the powder oxidizes and loses efficacy. (2) Not validating pH stability after mixing tranexamic acid into an oil-in-water or water-in-oil emulsion—pH can drift over time, especially if preservative is compromised. (3) Stacking tranexamic acid + kojic acid + hydroquinone or niacinamide at high concentrations and assuming synergy without stability or safety testing—mixing multiple actives requires bench-scale validation. (4) Listing concentrations on the label—many brands do this for transparency, but if the actual batch tests at a different concentration (due to manufacturing variance or degradation), you've created a compliance risk; use vaguer language like "contains tranexamic acid and kojic acid complex" unless you have validated batch-to-batch consistency. On the AJ Cosmo Labs app, your assigned cosmetic chemist will recommend safe, effective concentrations based on your target market's regulations and your formulation's pH and preservative system; they'll also provide a stability protocol to ensure your product maintains label claims throughout shelf life.
Ingredients in this answer: Tranexamic Acid · Niacinamide · Kojic Acid · Phenoxyethanol
Read the full guide on Private Label Tranexamic Acid Kojic Acid Underarm Cream →